Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.01 | uM | 7 | 1250.00 | 580.08 | 948.00 | 1814.50 | 0.5225 | 0.3479 |
| BT-20 | Lapatinib | 1 | uM | 7 | 1250.00 | 580.08 | 1777.00 | 1814.50 | 0.9793 | 0.9748 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 1250.00 | 580.08 | 1780.00 | 1814.50 | 0.9810 | 0.9768 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 1250.00 | 580.08 | 1799.00 | 1814.50 | 0.9915 | 0.9896 |
| BT-20 | Lapatinib | 0.31623 | uM | 7 | 1250.00 | 580.08 | 1923.00 | 1814.50 | 1.0598 | 1.0719 |
| BT-20 | Erlotinib | 10 | uM | 7 | 1250.00 | 580.08 | 1234.00 | 1814.50 | 0.6801 | 0.5822 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 1250.00 | 580.08 | 1577.00 | 1814.50 | 0.8691 | 0.8365 |
| BT-20 | 17-AAG | 0.0033113 | uM | 7 | 1250.00 | 580.08 | 1592.00 | 1814.50 | 0.8774 | 0.8471 |
| BT-20 | Lapatinib | 10 | uM | 7 | 1250.00 | 580.08 | 801.00 | 1814.50 | 0.4414 | 0.2167 |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 1742.00 | 1814.50 | 0.9600 | 0.9510 | |
| BT-20 | 0 | uM | 7 | 1250.00 | 580.08 | 3.00 | 1814.50 | 0.0017 | -0.9592 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 3.00 | 4133.00 | 0.0007 | -0.9747 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4256.00 | 4133.00 | 1.0298 | 1.0358 | |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 2500.00 | 1312.79 | 4297.00 | 4133.00 | 1.0397 | 1.0476 |
| BT-20 | Linsitinib | 0.031623 | uM | 7 | 2500.00 | 1312.79 | 4184.00 | 4133.00 | 1.0123 | 1.0149 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4011.00 | 4133.00 | 0.9705 | 0.9641 | |
| BT-20 | 17-AAG | 1 | uM | 7 | 2500.00 | 1312.79 | 1363.00 | 4133.00 | 0.3298 | 0.0229 |
| BT-20 | Linsitinib | 10 | uM | 7 | 2500.00 | 1312.79 | 3309.00 | 4133.00 | 0.8006 | 0.7485 |
| BT-20 | 17-AAG | 0.1 | uM | 7 | 2500.00 | 1312.79 | 1398.00 | 4133.00 | 0.3383 | 0.0387 |
| BT-20 | Lapatinib | 0.01 | uM | 7 | 2500.00 | 1312.79 | 4284.00 | 4133.00 | 1.0365 | 1.0438 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 2500.00 | 1312.79 | 1821.00 | 4133.00 | 0.4406 | 0.2187 |
| BT-20 | Lapatinib | 0.1 | uM | 7 | 2500.00 | 1312.79 | 4548.00 | 4133.00 | 1.1004 | 1.1191 |
| BT-20 | Lapatinib | 0.031623 | uM | 7 | 2500.00 | 1312.79 | 4643.00 | 4133.00 | 1.1234 | 1.1457 |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 2500.00 | 1312.79 | 3837.00 | 4133.00 | 0.9284 | 0.9122 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4340.00 | 4133.00 | 1.0501 | 1.0600 |